Lifecore Biomedical, Inc. \De\ financial data

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN
State of incorporation
DE
Fiscal year end
May 25
Former names
LANDEC CORP \CA\ (to 11/7/2022)
Latest financial report
10-Q - Q3 2024 - Oct 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 197 % +59.9%
Quick Ratio 104 % +96.4%
Debt-to-equity 3.01K % +230%
Return On Assets 2.63 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.9M shares
Common Stock, Shares, Outstanding 30.9M shares +1.45%
Entity Public Float 154M USD -15%
Common Stock, Value, Issued 31K USD +3.33%
Weighted Average Number of Shares Outstanding, Basic 30.9M shares +1.49%
Weighted Average Number of Shares Outstanding, Diluted 30.9M shares +1.49%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.62M USD -0.65%
Operating Income (Loss) -11.8M USD +56.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.78M USD -29.8%
Income Tax Expense (Benefit) 70K USD -82.1%
Net Income (Loss) Attributable to Parent 6.54M USD -50.9%
Earnings Per Share, Basic 0.22 USD/shares -51.4%
Earnings Per Share, Diluted 0.14 USD/shares -51.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.46M USD -55.7%
Accounts Receivable, after Allowance for Credit Loss, Current 25.1M USD
Inventory, Net 41.6M USD -0.12%
Assets, Current 74.2M USD -10.4%
Property, Plant and Equipment, Net 149M USD +9.17%
Operating Lease, Right-of-Use Asset 2.37M USD -42.9%
Intangible Assets, Net (Excluding Goodwill) 4.2M USD 0%
Goodwill 13.9M USD 0%
Other Assets, Noncurrent 3.43M USD -20.3%
Assets 247M USD +0.49%
Accounts Payable, Current 18M USD +14.8%
Employee-related Liabilities, Current 5.57M USD +23.2%
Contract with Customer, Liability, Current 3.2M USD +18%
Liabilities, Current 40.5M USD +14.4%
Contract with Customer, Liability, Noncurrent 4.79M USD +184%
Deferred Income Tax Liabilities, Net 443K USD -2.85%
Operating Lease, Liability, Noncurrent 1.73M USD -73.4%
Other Liabilities, Noncurrent 5.11M USD +2235%
Liabilities 207M USD -5.36%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -183M USD +3.45%
Stockholders' Equity Attributable to Parent -3.94M USD +71%
Liabilities and Equity 247M USD +0.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -643K USD +92.3%
Net Cash Provided by (Used in) Financing Activities 1.09M USD -62.7%
Net Cash Provided by (Used in) Investing Activities -3.39M USD +32.9%
Common Stock, Shares Authorized 75M shares +50%
Common Stock, Shares, Issued 30.9M shares +1.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.94M USD +71.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.52M USD -36.1%
Deferred Tax Assets, Valuation Allowance 46.2M USD -12.1%
Deferred Tax Assets, Gross 65.9M USD -0.68%
Operating Lease, Liability 5.69M USD -25.5%
Payments to Acquire Property, Plant, and Equipment 3.39M USD -32.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12M USD +82%
Lessee, Operating Lease, Liability, to be Paid 5.9M USD -34%
Property, Plant and Equipment, Gross 201M USD
Operating Lease, Liability, Current 3.96M USD +245%
Lessee, Operating Lease, Liability, to be Paid, Year Two 433K USD -64.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.02M USD +174%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure -43.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 211K USD -83.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 416K USD -66.1%
Deferred Tax Assets, Operating Loss Carryforwards 40.8M USD -8.54%
Preferred Stock, Shares Issued 43.3K shares +8.14%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.27M USD +8.36%
Lessee, Operating Lease, Liability, to be Paid, Year Four 302K USD -75.5%
Additional Paid in Capital 179M USD +1.76%
Preferred Stock, Shares Outstanding 43.3K shares +8.14%
Depreciation, Depletion and Amortization 1.99M USD -8.07%
Deferred Tax Assets, Net of Valuation Allowance 19.7M USD +42.5%
Share-based Payment Arrangement, Expense 7.09M USD +62.5%
Interest Expense 17.6M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%